Oruka Therapeutics, Inc.
USD94.10
+1.61 (+1.74%)
CEO
Lawrence Otto Klein
IPO Date
1997-08-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$92.50
Prev. Close
$92.49
Day Low
$90.26
Day High
$95.29
52W Low
$10.97
52W High
$95.38
Market Cap
$3.52B
Volume
0.39M
| -3.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -14.4% | -14.1% | 0.01 | 59.01 | -55.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -23.8% | -23.0% | 0.01 | 37.72 | -41.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -37.9% | -35.2% | 0.01 | 15.56 | -18.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -20.9% | -19.3% | 0.01 | 14.28 | -23.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -72.0% | -64.2% | 0.00 | 9.16 | -1.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -131.5% | -116.2% | 0.00 | 8.55 | -0.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -180.0% | -149.5% | 0.00 | 5.94 | -0.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -74.1% | -66.8% | 0.00 | 8.95 | -1.6 |
| -13.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.2% | -5.9% | 0.00 | 16.94 | -7.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -7.2% | -6.9% | 0.01 | 27.42 | -4.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -5.8% | -5.6% | 0.00 | 30.03 | -5.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.7% | -8.4% | 0.00 | 28.89 | -2.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.4% | -6.9% | 0.00 | 22.89 | -3.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -68.3% | -65.7% | 0.00 | 26.61 | -7.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -5.7% | -5.5% | 0.00 | 23.19 | -37.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -2.9% | -2.9% | 0.01 | 59.01 | -67.5 |